-
Featured Authors
-
Archives
- May 2013
- April 2013
- March 2013
- February 2013
- January 2013
- December 2012
- November 2012
- October 2012
- September 2012
- August 2012
- July 2012
- June 2012
- May 2012
- April 2012
- March 2012
- February 2012
- January 2012
- December 2011
- November 2011
- October 2011
- September 2011
- August 2011
- July 2011
- June 2011
- May 2011
- April 2011
- March 2011
- February 2011
- January 2011
- December 2010
- November 2010
- October 2010
- September 2010
- August 2010
- July 2010
- June 2010
- May 2010
- April 2010
- March 2010
- February 2010
- January 2010
- December 2009
- November 2009
- October 2009
- September 2009
- August 2009
- July 2009
- June 2009
- May 2009
- April 2009
- March 2009
- February 2009
- January 2009
- December 2008
- November 2008
- October 2008
- September 2008
- August 2008
- July 2008
- June 2008
- May 2008
- April 2008
- March 2008
- February 2008
-
Meta
Tag Archives: WHO
Implementing the WHO PIP Framework – Industry’s Role & Outlook
In May 2011, the World Health Organization (WHO) adopted the Pandemic Influenza Preparedness (PIP) Framework after nearly five years of contentious negotiations. As noted by Anne Huvos, WHO Secretariat, the two objectives of the PIP Framework are: (1) to improve sharing of influenza viruses with human pandemic potential; and (2) to achieve more predictable, efficient, and equitable access to benefits, such as vaccines and antiviral medicines, during future pandemics. The subject of a session at Read More >
If Biotech Builds…Will Financers Come?
Angie Drakulich from PharmaTech Talk writes: In many countries, it’s easy to get the health minister to understand the value of introducing a vaccine and related healthcare training and therapies to his or her population. It’s another thing to get the finance minister to buy into the effort. But healthcare education and training have made and continue to make great inroads into this area. Angie is part of our BIO Official Blog Program. Keep an Read More >
World Health Day: The Global Impact of Vaccines
As we celebrate World Health Day today, it is an opportunity to remember that vaccines represent one of the most important global health investments. The investment of time, money and dedication has brought enormous benefits to the world. According to the World Health Organization, immunizations save an estimated 2.5 million lives every year from diphtheria, tetanus, pertussis (whooping cough), and measles. Biotechnology is helping us improve existing vaccines and create new vaccines against infectious agents. Read More >
Pathogens and the Nagoya Protocol of the Convention on Biological Diversity
Some nations have argued that the recent Nagoya Protocol of the Convention of Biological Diversity (CBD) includes pathogens. The inclusion of pathogens in the Nagoya Protocol could adversely affect the world’s ability to control outbreaks of infectious disease. The following reasons demonstrate why pathogens are not and should not be included in the Nagoya Protocol. Contrary to the Mission of the CBD: The three main objectives of the CBD are; “The conservation of biological Read More >
Patently BIOtech
Leave a comment
Email This Post
Tags: ABS, ABS Protocol, Access and Benefit Sharing, access and benefit sharing protocol, access and benefits, CBD, conservation, Convention on Biological Diversity, Global Health, infectious disease, Nagoya Protocol, outbreak, Pandemic, Pathogen, Pathogens, sustainable use, WHO, World Health Organization
Tags: ABS, ABS Protocol, Access and Benefit Sharing, access and benefit sharing protocol, access and benefits, CBD, conservation, Convention on Biological Diversity, Global Health, infectious disease, Nagoya Protocol, outbreak, Pandemic, Pathogen, Pathogens, sustainable use, WHO, World Health Organization
